|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 2 of 48 found articles
| Title: |
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial |
| Author: |
Kelley, Robin Kate Rimassa, Lorenza Cheng, Ann-Lii Kaseb, Ahmed Qin, Shukui Zhu, Andrew X Chan, Stephen L Melkadze, Tamar Sukeepaisarnjaroen, Wattana Breder, Valery Verset, Gontran Gane, Edward Borbath, Ivan Rangel, Jose David Gomez Ryoo, Baek-Yeol Makharadze, Tamta Merle, Philippe Benzaghou, Fawzi Banerjee, Kamalika Hazra, Saswati Fawcett, Jonathan Yau, Thomas |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 23 () nr. 8 pages 995-1008 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 2 of 48 found articles
| << previous | next >> |